1. Reprogrammed macrophage-derived nanovesicle-lipid nanoparticle hybrids for cardiac siRUNX1 delivery: Therapeutic evaluation in Ang II-induced cardiac remodeling
Lee J, Mun D, Kang Jy, Yoo G, Park M, Chung S, Et Al.
Targeted delivery of small interfering RNA (siRNA) to the heart remains challenging because conventional lipid nanoparticles (LNPs) predominantly accumulate in the liver following systemic administration. To improve cardiac siRNA delivery, we developed a biomimetic hybrid nanoplatform by co-extruding siRUNX1-loaded…
Read the article